Luis Carlos López Romero Profile
Luis Carlos López Romero

@LcLopezR

Followers
111
Following
73
Statuses
88

Nephrologist Hospital de Manises, Valencia. PhD candidate IISLAFE/UV

Valencia, España
Joined July 2021
Don't wanna be here? Send us removal request.
@LcLopezR
Luis Carlos López Romero
1 month
RT @JASN_News: Torsemide is proposed to have clinically important pharmacokinetic and pharmacodynamic advantages over furosemide. This stud…
0
36
0
@LcLopezR
Luis Carlos López Romero
1 month
RT @JASN_News: Predialysis nephrology care and KRT-directed education (KDE) are essential for incident home dialysis use. This study found…
0
6
0
@LcLopezR
Luis Carlos López Romero
2 months
RT @JonathanNefro: En hipertensión arterial, clortalidona, comparado a hidroclorotiazida, no fue superior en la prevención de ninguno de lo…
0
25
0
@LcLopezR
Luis Carlos López Romero
2 months
RT @JonathanNefro: La estimación de la proteinuria con el cociente de proteínas/creatinina urinaria es, prácticamente perfecta, al comparar…
0
86
0
@LcLopezR
Luis Carlos López Romero
3 months
RT @AJKDonline: The December 2024 issue is now available: Highlights: - Cumulative Blood Pressure and CKD - Kidne…
0
7
0
@LcLopezR
Luis Carlos López Romero
3 months
RT @MRCEMPREP: 🚑 You’re the Doctor: A 25-year-old marathon runner collapses at the finish line. Bystanders say he was confused and agitated…
0
518
0
@LcLopezR
Luis Carlos López Romero
3 months
RT @CJASN: Albuminuria testing is an easy way to identify, early on, a higher risk of cardiovascular and kidney morbidity and mortality in…
0
27
0
@LcLopezR
Luis Carlos López Romero
3 months
RT @AJKDonline: #KDOQI Commentary on @goKDIGO 2024 Clinical Practice Guideline for Evaluation & Management of CKD
0
28
0
@LcLopezR
Luis Carlos López Romero
4 months
RT @JonathanNefro: Dejemos de suplementar vitamina D (cole/ergocalciferol) en personas con enfermedad renal crónica. No tiene efectos clíni…
0
111
0
@LcLopezR
Luis Carlos López Romero
6 months
RT @mapefer3: Excited to share our new study on inflammation in HD patients! 🔥 Using metabolomics & LASSO, we found 🔑 differences in autoph…
0
9
0
@LcLopezR
Luis Carlos López Romero
8 months
Our study on adult patients with X-linked hypophosphatemia may offer valuable insights into the natural progression in adults, which can aid in better clinical management. Here we show our results. @jbroseta @juliohe41662387 @SVNefro
0
3
15
@LcLopezR
Luis Carlos López Romero
9 months
RT @CJASN: Sotagliflozin is a dual SGLT1 and 2 inhibitor that has demonstrated CV benefits. This study found sotagliflozin reduced the risk…
0
62
0
@LcLopezR
Luis Carlos López Romero
10 months
RT @KidneyMed: Hemodiafiltration versus Hemodialysis in End-Stage Kidney Disease: A Systematic Review and Meta-analysis Authors demonstra…
0
38
0
@LcLopezR
Luis Carlos López Romero
11 months
What mechanisms exist behind hypertension and cardiovascular risk in patients with this tubulopathy? Here we show you our results. @jbroseta @juliohe41662387 @SVNefro @SENefrologia #mdpiijms via @IJMS_MDPI
2
9
14
@LcLopezR
Luis Carlos López Romero
1 year
RT @jbroseta: 🔈 Proud our 📝 "Lipidic profiles of patients starting #PD suggest an increased CV risk beyond classical dyslipidemia biomarker…
0
6
0
@LcLopezR
Luis Carlos López Romero
2 years
RT @NatRevNeph: The glomerulus in health and disease
Tweet media one
0
294
0
@LcLopezR
Luis Carlos López Romero
2 years
RT @irisvibo: Nuestro artículo sobre el rol del nefrólogo en el trasplante de órgano sólido no renal ya est�� disponible
0
10
0
@LcLopezR
Luis Carlos López Romero
2 years
RT @CKJsocial: 🤔Wondering about protocol biopsies or new biomarkers for assessing renal response in #ANCA #vasculitis? 👀hAAVe a look at the…
0
41
0
@LcLopezR
Luis Carlos López Romero
2 years
RT @ralcazara: Registro de diálisis y trasplante de la ERA - 2020. En @CKJsocial - - ¿Cómo nos comparamos? Ganamos…
0
9
0
@LcLopezR
Luis Carlos López Romero
2 years
RT @CJASN: The role of albumin in kidney injury remains controversial. Is it a marker of advancing glomerular injury, a marker of proximal…
0
47
0